These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 12672048

  • 1. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU, Plötz S, Simon D, Seitzer U, Braathen LR, Menz G, Straumann A, Dummer R, Levi-Schaffer F.
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [Abstract] [Full Text] [Related]

  • 2. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M, Peterson C, Venge P.
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [Abstract] [Full Text] [Related]

  • 3. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV, Bizer C, Volgger W, Simon HU.
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [Abstract] [Full Text] [Related]

  • 4. Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit.
    Plumas J, Gruart V, Aldebert D, Truong MJ, Capron M, Capron A, Prin L.
    Eur J Immunol; 1991 May; 21(5):1265-70. PubMed ID: 2037012
    [Abstract] [Full Text] [Related]

  • 5. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M.
    Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651
    [Abstract] [Full Text] [Related]

  • 6. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T, Knowles A, Li MS, Sun L, Tooze JA, Zabucchi G, Spry CJ.
    Immunology; 1994 Oct 15; 83(2):313-8. PubMed ID: 7835953
    [Abstract] [Full Text] [Related]

  • 7. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
    Takafuji S, Ohtoshi T, Takizawa H, Tadokoro K, Ito K.
    J Immunol; 1996 May 15; 156(10):3980-5. PubMed ID: 8621939
    [Abstract] [Full Text] [Related]

  • 8. Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration.
    Sosman JA, Bartemes K, Offord KP, Kita H, Fisher SG, Kefer C, Ellis TA, Fisher RI, Higgins TJ, Gleich GJ.
    Clin Cancer Res; 1995 Aug 15; 1(8):805-12. PubMed ID: 9816049
    [Abstract] [Full Text] [Related]

  • 9. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
    Carlson M, Raab Y, Peterson C, Hällgren R, Venge P.
    Am J Gastroenterol; 1999 Jul 15; 94(7):1876-83. PubMed ID: 10406252
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-2 activates human peripheral blood eosinophils.
    Hoenstein R, Admon D, Solomon A, Norris A, Moqbel R, Levi-Schaffer F.
    Cell Immunol; 2001 Jun 15; 210(2):116-24. PubMed ID: 11520078
    [Abstract] [Full Text] [Related]

  • 11. Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5.
    Trüeb RM, Lübbe J, Torricelli R, Panizzon RG, Wüthrich B, Burg G.
    Arch Dermatol; 1997 Feb 15; 133(2):203-6. PubMed ID: 9041834
    [Abstract] [Full Text] [Related]

  • 12. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
    Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, Blaser K, Wüthrich B, Simon HU.
    J Immunol; 2002 Jul 15; 169(2):1021-7. PubMed ID: 12097410
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.
    Tai PC, Capron M, Bakes DM, Barkans J, Spry CJ.
    Clin Exp Immunol; 1986 Mar 15; 63(3):728-37. PubMed ID: 3708911
    [Abstract] [Full Text] [Related]

  • 14. [Inflammatory role of eosinophil in allergic reactions].
    Kimura I, Takahashi K.
    Nihon Rinsho; 1993 Mar 15; 51(3):651-6. PubMed ID: 8492439
    [Abstract] [Full Text] [Related]

  • 15. [Eosinophils in immediate allergic reactions].
    Takizawa H.
    Nihon Rinsho; 1993 Mar 15; 51(3):664-8. PubMed ID: 8388063
    [Abstract] [Full Text] [Related]

  • 16. Anti-interleukin-5 antibody therapy in eosinophilic diseases.
    Simon D, Braathen LR, Simon HU.
    Pathobiology; 2005 Mar 15; 72(6):287-92. PubMed ID: 16582580
    [Abstract] [Full Text] [Related]

  • 17. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S, Tadokoro K, Ito K.
    Allergy; 1996 Aug 15; 51(8):563-8. PubMed ID: 8874660
    [Abstract] [Full Text] [Related]

  • 18. Eosinophils in atopic dermatitis.
    Leiferman KM.
    Allergy; 1989 Aug 15; 44 Suppl 9():20-6. PubMed ID: 2683840
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I, Olofsson T, Olsson I.
    Immunology; 1984 Jan 15; 51(1):1-8. PubMed ID: 6317543
    [Abstract] [Full Text] [Related]

  • 20. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
    Lampinen M, Oberg G, Venge P, Carlson M.
    APMIS; 2006 Nov 15; 114(11):757-63. PubMed ID: 17078855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.